Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 10, 2009, Pages 4822-4827

  Gericke, Adrian ^a   Mayer, Veronique G A ^a   Steege, Andreas ^b   Patzak, Andreas ^b   Neumann, Ulrike ^b   Grus, Franz H ^a   Joachim, Stephanie C ^a   Choritz, Lars ^a   Wess, Jürgen ^c   Pfeiffer, Norbert ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CARBACHOL; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; MESSENGER RNA; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; BLOOD VESSEL REACTIVITY; CHOLINERGIC ACTIVITY; CHOLINERGIC RECEPTOR BLOCKING; CHOLINERGIC STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; ISOLATED ORGAN; KNOCKOUT MOUSE; MICROPIPETTE; MICROSCOPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPHTHALMIC ARTERY; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VASOCONSTRICTION; VASODILATATION; VIDEORECORDING; WILD TYPE; ANIMAL; DRUG EFFECT; MALE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETYLCHOLINE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; BRADYKININ; CARBACHOL; CHOLINERGIC AGENTS; GENE EXPRESSION; MALE; MICE; MICE, KNOCKOUT; NITROPRUSSIDE; OPHTHALMIC ARTERY; PHENYLEPHRINE; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M5; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASODILATION; VASODILATOR AGENTS; VIDEO RECORDING;

EID: 70349580529     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3600     Document Type: Article

References (50)

1. Friedman E, Krupsky S, Lane AM, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995;102: 640-646.
2. Pournaras CJ, Logean E, Riva CE, et al. Regulation of subfoveal choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:1581-1586.
3. Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:358-363.
4. Dimitrova G, Kato S, Yamashita H, et al. Relation between retrobulbar circulation and progression of diabetic retinopathy. Br J Ophthalmol. 2003;87:622-625.
5. Savage HI, Hendrix JW, Peterson DC, Young H, Wilkinson CP. Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45: 4504-4509.
6. Nagaoka T, Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol. 2004;88:1060-1063.
7. Collignon-Robe NJ, Feke GT, Rizzo JF III. Optic nerve head circulation in nonarteritic anterior ischemic optic neuropathy and optic neuritis. Ophthalmology. 2004;111:1663-1672.
8. Kaup M, Plange N, Arend KO, Remky A. Retrobulbar haemodynamics in non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 2006;90:1350-1353.
9. Findl O, Rainer G, Dallinger S, et al. Assessment of optic disk blood flow in patients with open-angle glaucoma. Am J Ophthalmol. 2000;130:589-596.
10. Emre M, Orgul S, Gugleta K, Flammer J. Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol. 2004;88:662-666.
11. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder: the Wiggers Award Lecture. Am J Physiol Heart Circ Physiol. 2006;291:H985-H1002.
12. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology. 2001;108:705-710.
13. Malecki MT, Osmenda G, Walus-Miarka M, et al. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction. Eur J Clin Invest. 2008;38: 925-930.
14. Potarazu SV. Ischemic optic neuropathy: models for mechanism of disease. Clin Neurosci. 1997;4:264-269.
15. Resch H, Garhofer G, Fuchsjager-Mayrl G, Hommer A, Schmetterer L. Endothelial dysfunction in glaucoma. Acta Ophthalmol. 2009; 87:4-12.
16. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
17. Faraci FM, Sigmund CD. Vascular biology in genetically altered mice: smaller vessels, bigger insight. Circ Res. 1999;85:1214-1225.
18. Klonizakis M, Tew G, Michaels J, Saxton J. Impaired microvascular endothelial function is restored by acute lower-limb exercise in post-surgical varicose vein patients. Microvasc Res. 2009;77:158-162.
19. Henry E, Newby DE, Webb DJ, O'Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999;40:1710-1714.
20. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
21. Leung HS, Leung FP, Yao X, et al. Endothelial mediators of the acetylcholine-induced relaxation of the rat femoral artery. Vascul Pharmacol. 2006;44:299-308.
22. Okubo H, Gherezhiher T, Koss MC. Long posterior ciliary arterial blood flow and systemic blood pressure. Invest Ophthalmol Vis Sci. 1990;31:819-826.
23. Mann RM, Riva CE, Stone RA, Barnes GE, Cranstoun SD. Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci. 1995;36:925-930.
24. Shaikh MH, Mars JS. The acute effect of pilocarpine on pulsatile ocular blood flow in ocular hypertension. Eye. 2001;15:63-66.
25. Caulfield MP, Birdsall NJ. International Union of Pharmacology, XVII: classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998;50:279-290.
26. Hosey MM. Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors. FASEB J. 1992;6: 845-852.
27. Phillips JK, Vidovic M, Hill CE. Variation in mRNA expression of alpha-adrenergic, neurokinin and muscarinic receptors amongst four arteries of the rat. J Auton Nerv Syst. 1997;62:85-93.
28. Elhusseiny A, Cohen Z, Olivier A, Stanimirovic DB, Hamel E. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J Cereb Blood Flow Metab. 1999;19:794-802.
29. 5 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A. 2001;98: 14096-14101.
30. 3 receptors in response to acetylcholine. Arterioscler Thromb Vasc Biol. 2004;24:1253-1258.
31. Zagvazdin Y, Fitzgerald ME, Reiner A. Role of muscarinic cholinergic transmission in Edinger-Westphal nucleus-induced choroidal vasodilation in pigeon. Exp Eye Res. 2000;70:315-327.
32. Steinle JJ, Smith PG. Presynaptic muscarinic facilitation of parasympathetic neurotransmission after sympathectomy in the rat choroid. J Pharmacol Exp Ther. 2000;294:627-632.
33. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol. 1996;10:69-99.
34. 5 muscarinic receptors expressed in CHO-K1 cells. Br J Pharmacol. 1999;127: 590-596.
35. 3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 2001;410:207-212.
36. Eglen RM, Watson N. Selective muscarinic receptor agonists and antagonists. Pharmacol Toxicol. 1996;78:59-68.
37. 3 receptor in endothelium- dependent vasodilatation in mouse arteries. J Cardiovasc Pharmacol. 2008;51:505-512.
38. -/- mice. Eur J Pharmacol. 2004;493:127-132.
39. Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res. 1999;69:413-429.
40. Jandrasits K, Polak K, Luksch A, et al. Effects of atropine and propranolol on retinal vessel diameters during isometric exercise. Ophthalmic Res. 2001;33:185-190.
41. Polska E, Luksch A, Schering J, et al. Propranolol and atropine do not alter choroidal blood flow regulation during isometric exercise in healthy humans. Microvasc Res. 2003;65:39-44.
42. Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res. 2000;32:249-256.
43. Pournaras CJ, Rungger-Brandle E, Riva CE, Hardarson SH, Stefansson E. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res. 2008;27:284-330.
44. Chakravarthy U, Hayes RG, Stitt AW, McAuley E, Archer DB. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes. 1998;47:945-952.
45. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16:242-260.
46. Holdright DR, Clarke D, Fox K, Poole-Wilson PA, Collins P. The effects of intracoronary substance P and acetylcholine on coronary blood flow in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 1994;15:1537-1544.
47. Matsumoto T, Horie H, Minai K, et al. Coronary vasomotor responses to bradykinin and acetylcholine in patients with coronary spastic angina. Jpn Circ J. 2001;65:1052-1056.
48. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it: myth and reality. Prog Retin Eye Res. 2001;20: 563-593.
49. Feke GT. Retrobulbar haemodynamics in non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 2006;90:1334-1335.
50. Schmetterer L, Garhofer G. How can blood flow be measured? Surv Ophthalmol. 2007;52(suppl 2):S134-S138.